Sach, T. (2018) Safety gains don't translate into reduced costs or increased QALYs for doxycycline compared with prednisolone for patients with bullous pemphigoid. British Journal of Dermatology, 178 (2), 320-321. (doi:10.1111/bjd.16226).
Record type:
Article
This record has no associated files available for download.
More information
Published date: 1 February 2018
Keywords:
Cost-Benefit Analysis, Doxycycline, Humans, Pemphigoid, Bullous, Prednisolone, Quality-Adjusted Life Years
Identifiers
Local EPrints ID: 480873
URI: http://eprints.soton.ac.uk/id/eprint/480873
ISSN: 0007-0963
PURE UUID: 782a6edd-d085-4dd8-bd5e-eeb170c6c861
Catalogue record
Date deposited: 10 Aug 2023 16:40
Last modified: 17 Mar 2024 04:20
Export record
Altmetrics
Contributors
Author:
T. Sach
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.